REQUEST A DEMO
Total
USD $0.00
Search more companies

Zuellig Pharma Korea Co.,Ltd. (South Korea)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Zuellig Pharma Korea Co.,Ltd. Profile Updated: February 06, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Zuellig Pharma Korea Co.,Ltd. is based in South Korea. The head office is in Seoul. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was first established on January 15, 1997. It currently has a total number of 227 (2026) employees. In 2024, the company reported a net sales revenue increase of 4.76%. Its’ total assets recorded a growth of 38.66%. In 2024, Zuellig Pharma Korea Co.,Ltd.’s net profit margin decreased by 0.1%.

Headquarters
Hangang-daero Yongsan-gu Seoul, 3rd Floor, 92
Seoul; Seoul; Postal Code: 140702

Contact Details: Purchase the Zuellig Pharma Korea Co.,Ltd. report to view the information.

Website: http://www.zuelligpharma.com

Basic Information
Total Employees:
Purchase the Zuellig Pharma Korea Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Zuellig Pharma Korea Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Zuellig Pharma Korea Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Zuellig Pharma Korea Co.,Ltd. report to view the information.
Incorporation Date:
January 15, 1997
Key Executives
Purchase this report to view the information.
Chairman
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Kyungdongsa Co.,Ltd.
Company Performance
Financial values in the chart are available after Zuellig Pharma Korea Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
4.76%
Total Operating Revenue
4.76%
Operating Profit
-0.01%
EBITDA
-1.18%
Net Profit/Loss for the Period
-14.32%
Total Assets
38.66%
Total Equity
51.21%
Operating Profit Margin
-0.02%
Net Profit Margin
-0.1%
Return on Equity (ROE)
-34.55%
Debt / Equity
78%
Quick Ratio
-0.03%
Cash Ratio
0.15%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?